Brochure
2 Aug 2021

Lessons Learned: Choosing & Managing a CDMO

PPTX 111 kB
Download

Lessons Learned: Choosing & Managing a CDMOAvéma Pharma Solutions, a division of PL Developments (PLD), is in the unique position being both a consumer and supplier of global CDMO services for both OTC and rX products. In this presentation, we’ll explore the lessons we have learned from managing our own CMOs that have allowed us to build a better CDMO model for our Avéma customers. We’ll address the areas that can help speed up your time-to-market, keep development costs under control, and smooth the FDA approval and commercial launch process. Watch our webinar at https://app.webinar.net/K2OlZE6JLx9?mcc=WebsitePost

Read more Show less
Content provided by our supplier

Avema Pharma Solutions

  • US
  • 2017
    On CPHI since
  • 1
    Certificates
Company types
Contract Service
View company profile

Other Content from Avema Pharma Solutions (1)

  • The Promise of Gummies as a Drug Delivery System

    Video The Promise of Gummies as a Drug Delivery System

    The global gummy vitamin market is expected to reach 10.6 billion by 2025 and gummies are gaining traction as a drug delivery system -- especially for children and seniors who resist taking pills, capsules and liquids. Mitchell Slade, who brings more than 20 years of gummy manufacturing experience at Nature’s Bounty to the table, will address the challenges of developing gummies beyond supplements, such ensuring consistent dosage, production and taste. Avéma/PLD has a world-class GDUFA facility that is CFR 211 and CFR 111 certified, uses a starchless gummy manufacturing process and brings 40+ years of formulating experience to the development of innovative drug delivery systems.
    2024-05-17